Breaking News Instant updates and real-time market news.

$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

15:16
09/21/20
09/21
15:16
09/21/20
15:16

NYSE market internals summary

Volume is above average for this time of day. Breadth is bearish across the board. Advancing Issues: 310 / Declining Issues: 2751 -- for a ratio of 0.1 to 1. Advancing Volume: 291,386,000 / Declining Volume: 3,007,955,000 -- for a ratio of 0.1 to 1. New 52-Week Highs: 29 / New 52-Week Lows: 46.

TODAY'S FREE FLY STORIES

Technical Analysis
NASDAQ market internals summary » 11:17
11/27/20
11/27
11:17
11/27/20
11:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Technical Analysis
NYSE market internals summary » 11:16
11/27/20
11/27
11:16
11/27/20
11:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Options
FreightCar America call volume off the rails as shares jump 50% » 11:00
11/27/20
11/27
11:00
11/27/20
11:00
RAIL

FreightCar America

$2.85 /

+0.85 (+42.50%)

FreightCar America call…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RAIL FreightCar America
$2.85 /

+0.85 (+42.50%)

RAIL FreightCar America
$2.85 /

+0.85 (+42.50%)

Hot Stocks
Boxlight teases upcoming presentation at ISTE20 in blog post » 10:58
11/27/20
11/27
10:58
11/27/20
10:58
BOXL

Boxlight

$1.42 /

-0.025 (-1.73%)

In a post to its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BOXL Boxlight
$1.42 /

-0.025 (-1.73%)

BOXL Boxlight
$1.42 /

-0.025 (-1.73%)

10/05/20 Maxim
Boxlight price target raised to $6 from $4 at Maxim
10/01/20 Alliance Global Partners
Boxlight price target raised to $4 from $2.75 at Alliance Global Partners
08/17/20 Maxim
Boxlight price target raised to $4 from $2 at Maxim
08/14/20 Alliance Global Partners
Boxlight price target raised to $2.75 from $1.75 at Alliance Global Partners
BOXL Boxlight
$1.42 /

-0.025 (-1.73%)

  • 29
    Jul
  • 09
    Jun
BOXL Boxlight
$1.42 /

-0.025 (-1.73%)

Conference/Events
Conduent management to meet virtually with Needham » 10:54
11/27/20
11/27
10:54
11/27/20
10:54
CNDT

Conduent

$4.46 /

-0.015 (-0.34%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CNDT Conduent
$4.46 /

-0.015 (-0.34%)

CNDT Conduent
$4.46 /

-0.015 (-0.34%)

04/14/20 JPMorgan
JPMorgan downgrades Conduent to Neutral with turnaround 'stretched' by pandemic
04/13/20 JPMorgan
Conduent downgraded to Neutral from Overweight at JPMorgan
CNDT Conduent
$4.46 /

-0.015 (-0.34%)

CNDT Conduent
$4.46 /

-0.015 (-0.34%)

CNDT Conduent
$4.46 /

-0.015 (-0.34%)

CNDT Conduent
$4.46 /

-0.015 (-0.34%)

Conference/Events
Cerence management to meet virtually with Needham » 10:54
11/27/20
11/27
10:54
11/27/20
10:54
CRNC

Cerence

$91.17 /

+4.5 (+5.19%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRNC Cerence
$91.17 /

+4.5 (+5.19%)

CRNC Cerence
$91.17 /

+4.5 (+5.19%)

11/18/20 Goldman Sachs
Cerence assumed with a Buy from Sell at Goldman Sachs
11/17/20 Needham
Cerence price target raised to $95 from $82 at Needham
11/17/20 Craig-Hallum
Cerence price target raised to $90 from $61 at Craig-Hallum
11/17/20 RBC Capital
Cerence downgraded to Sector Perform from Outperform at RBC Capital
CRNC Cerence
$91.17 /

+4.5 (+5.19%)

CRNC Cerence
$91.17 /

+4.5 (+5.19%)

CRNC Cerence
$91.17 /

+4.5 (+5.19%)

Options
Palantir options lead single stocks with 600k contract first hour » 10:50
11/27/20
11/27
10:50
11/27/20
10:50
PLTR

Palantir

$30.30 /

+1.27 (+4.37%)

Palantir options lead…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLTR Palantir
$30.30 /

+1.27 (+4.37%)

PLTR Palantir
$30.30 /

+1.27 (+4.37%)

11/13/20
Fly Intel: Top five analyst downgrades
11/13/20 Jefferies
Palantir price target raised to $18 from $13 at Jefferies
11/13/20 RBC Capital
Palantir price target raised to $15 from $11 at RBC Capital
11/13/20 Morgan Stanley
Morgan Stanley downgrades Palantir to Equal Weight after spike in share price
PLTR Palantir
$30.30 /

+1.27 (+4.37%)

PLTR Palantir
$30.30 /

+1.27 (+4.37%)

PLTR Palantir
$30.30 /

+1.27 (+4.37%)

PLTR Palantir
$30.30 /

+1.27 (+4.37%)

Options
Sorrento Therapeutics call volume above normal and directionally bullish » 10:45
11/27/20
11/27
10:45
11/27/20
10:45
SRNE

Sorrento Therapeutics

$7.99 /

+1.09 (+15.80%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SRNE Sorrento Therapeutics
$7.99 /

+1.09 (+15.80%)

SRNE Sorrento Therapeutics
$7.99 /

+1.09 (+15.80%)

07/31/20 H.C. Wainwright
Sorrento Therapeutics price target raised to $30 from $24 at H.C. Wainwright
07/20/20 Dawson James
Sorrento antibody cocktail effort could move quickly, says Dawson James
05/26/20 Dawson James
Sorrento Therapeutics initiated with a Buy at Dawson James
SRNE Sorrento Therapeutics
$7.99 /

+1.09 (+15.80%)

SRNE Sorrento Therapeutics
$7.99 /

+1.09 (+15.80%)

SRNE Sorrento Therapeutics
$7.99 /

+1.09 (+15.80%)

Hot Stocks
Moderna, Novavax advance as questions on AstraZeneca COVID vaccine arise » 10:41
11/27/20
11/27
10:41
11/27/20
10:41
MRNA

Moderna

$124.79 /

+15.61 (+14.30%)

, NVAX

Novavax

$118.65 /

+16.13 (+15.73%)

, AZN

AstraZeneca

$52.14 /

-0.46 (-0.87%)

Shares of smaller…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$124.79 /

+15.61 (+14.30%)

NVAX Novavax
$118.65 /

+16.13 (+15.73%)

AZN AstraZeneca
$52.14 /

-0.46 (-0.87%)

MRNA Moderna
$124.79 /

+15.61 (+14.30%)

07:39 Today Argus
AstraZeneca's COVID vaccine faces high bar for FDA authorization, says Argus
11/25/20 Goldman Sachs
Moderna price target raised to $139 from $107 at Goldman Sachs
11/23/20
Fly Intel: Top five analyst initiations
11/23/20 Wells Fargo
Moderna initiated with an Equal Weight at Wells Fargo
NVAX Novavax
$118.65 /

+16.13 (+15.73%)

11/17/20 H.C. Wainwright
Novavax price target lowered to $207 from $290 at H.C. Wainwright
10/30/20 Cantor Fitzgerald
Cantor says Novavax vaccine could be 'best-in-class,' but not 'first-in-class'
10/22/20 B. Riley Securities
Novavax price target lowered to $223 from $257 at B. Riley Securities
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
AZN AstraZeneca
$52.14 /

-0.46 (-0.87%)

07:39 Today Argus
AstraZeneca's COVID vaccine faces high bar for FDA authorization, says Argus
06:25 Today Citi
Citi opens 'positive catalyst watch' on AstraZeneca after vaccine selloff
11/24/20 Piper Sandler
Astra vaccine results 'de-risking' for Altimmune, says Piper Sandler
11/23/20 Morgan Stanley
AstraZeneca price target raised to 9,400 GBp from 9,000 GBp at Morgan Stanley
MRNA Moderna
$124.79 /

+15.61 (+14.30%)

NVAX Novavax
$118.65 /

+16.13 (+15.73%)

AZN AstraZeneca
$52.14 /

-0.46 (-0.87%)

  • 19
    May
  • 12
    Feb
MRNA Moderna
$124.79 /

+15.61 (+14.30%)

NVAX Novavax
$118.65 /

+16.13 (+15.73%)

AZN AstraZeneca
$52.14 /

-0.46 (-0.87%)

MRNA Moderna
$124.79 /

+15.61 (+14.30%)

NVAX Novavax
$118.65 /

+16.13 (+15.73%)

AZN AstraZeneca
$52.14 /

-0.46 (-0.87%)

MRNA Moderna
$124.79 /

+15.61 (+14.30%)

NVAX Novavax
$118.65 /

+16.13 (+15.73%)

AZN AstraZeneca
$52.14 /

-0.46 (-0.87%)

Options
GameStop call volume above normal and directionally bullish » 10:25
11/27/20
11/27
10:25
11/27/20
10:25
GME

GameStop

$16.00 /

+1.25 (+8.47%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GME GameStop
$16.00 /

+1.25 (+8.47%)

GME GameStop
$16.00 /

+1.25 (+8.47%)

10/12/20 Jefferies
Jefferies 'pressing pause' on GameStop, downgrades to Hold
10/12/20 Jefferies
GameStop downgraded to Hold from Buy at Jefferies
10/09/20 Benchmark
GameStop price target raised to $6 from $3 at Benchmark
10/08/20 Jefferies
Microsoft deal net positive to GameStop thesis, says Jefferies
GME GameStop
$16.00 /

+1.25 (+8.47%)

GME GameStop
$16.00 /

+1.25 (+8.47%)

GME GameStop
$16.00 /

+1.25 (+8.47%)

GME GameStop
$16.00 /

+1.25 (+8.47%)

Periodicals
About 115,000 Tesla vehicles probed for suspension issues by NHTSA, Reuters says » 10:24
11/27/20
11/27
10:24
11/27/20
10:24
TSLA

Tesla

$592.95 /

+19.09 (+3.33%)

The U.S. National Highway…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$592.95 /

+19.09 (+3.33%)

TSLA Tesla
$592.95 /

+19.09 (+3.33%)

07:13 Today BofA
BofA positive on long-term share gains for NIO Inc. after hosting calls
11/18/20
Fly Intel: Top five analyst upgrades
11/18/20 Morgan Stanley
Morgan Stanley upgrades Tesla on 'profound model shift' to recurring sales
11/18/20 Morgan Stanley
Tesla upgraded to Overweight from Equal Weight at Morgan Stanley
TSLA Tesla
$592.95 /

+19.09 (+3.33%)

  • 14
    Feb
TSLA Tesla
$592.95 /

+19.09 (+3.33%)

TSLA Tesla
$592.95 /

+19.09 (+3.33%)

TSLA Tesla
$592.95 /

+19.09 (+3.33%)

Conference/Events
Truist leisure/gaming analysts hold an analyst/industry conference call » 10:23
11/27/20
11/27
10:23
11/27/20
10:23
GPN

Global Payments

$197.28 /

+0.12 (+0.06%)

Leisure/Gaming Analysts,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GPN Global Payments
$197.28 /

+0.12 (+0.06%)

GPN Global Payments
$197.28 /

+0.12 (+0.06%)

10/30/20 Truist
Global Payments price target lowered to $200 from $235 at Truist
10/20/20 JPMorgan
Global Payments price target raised to $209 from $200 at JPMorgan
10/08/20 Needham
Green Dot price target raised to $70 from $62 at Needham
10/06/20 Credit Suisse
Fiserv upgraded to Outperform at Credit Suisse on improving mix and valuation
GPN Global Payments
$197.28 /

+0.12 (+0.06%)

GPN Global Payments
$197.28 /

+0.12 (+0.06%)

GPN Global Payments
$197.28 /

+0.12 (+0.06%)

Technical Analysis
NASDAQ market internals summary » 10:17
11/27/20
11/27
10:17
11/27/20
10:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Recommendations
Stifel says license deal 'good' for Biogen, takes some upside off table for Sage » 10:16
11/27/20
11/27
10:16
11/27/20
10:16
BIIB

Biogen

$241.73 /

-0.32 (-0.13%)

, SAGE

Sage Therapeutics

$79.50 /

-3.11 (-3.76%)

Stifel analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIIB Biogen
$241.73 /

-0.32 (-0.13%)

SAGE Sage Therapeutics
$79.50 /

-3.11 (-3.76%)

BIIB Biogen
$241.73 /

-0.32 (-0.13%)

11/10/20 Truist
Truist raises Biogen price target to $443, views aducanumab approval as 'likely'
11/10/20 DZ Bank
Biogen upgraded to Buy from Hold at DZ Bank
11/09/20 BMO Capital
Biogen price target lowered to $253 from $343 at BMO Capital
11/09/20 SVB Leerink
Biogen price target lowered to $382 from $402 at SVB Leerink
SAGE Sage Therapeutics
$79.50 /

-3.11 (-3.76%)

11/19/20 Oppenheimer
Sage Therapeutics price target raised to $94 from $65 at Oppenheimer
11/16/20
Fly Intel: Top five analyst downgrades
11/16/20 Morgan Stanley
Morgan Stanley downgrades Sage Therapeutics amid 'reasonable' expectations
11/16/20 Morgan Stanley
Sage Therapeutics downgraded to Equal Weight from Overweight at Morgan Stanley
BIIB Biogen
$241.73 /

-0.32 (-0.13%)

SAGE Sage Therapeutics
$79.50 /

-3.11 (-3.76%)

BIIB Biogen
$241.73 /

-0.32 (-0.13%)

BIIB Biogen
$241.73 /

-0.32 (-0.13%)

SAGE Sage Therapeutics
$79.50 /

-3.11 (-3.76%)

BIIB Biogen
$241.73 /

-0.32 (-0.13%)

BIIB Biogen
$241.73 /

-0.32 (-0.13%)

Technical Analysis
NYSE market internals summary » 10:16
11/27/20
11/27
10:16
11/27/20
10:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Options
Rite Aid put volume heavy and directionally bearish » 10:15
11/27/20
11/27
10:15
11/27/20
10:15
RAD

Rite Aid

$12.57 /

+ (+0.00%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RAD Rite Aid
$12.57 /

+ (+0.00%)

RAD Rite Aid
$12.57 /

+ (+0.00%)

11/17/20 Oppenheimer
Amazon's Pharmacy push should continue to disrupt supply chain, says Oppenheimer
11/17/20 Goldman Sachs
Goldman says Amazon news likely to pressure entire pharmacy supply chain
09/25/20 Deutsche Bank
Rite Aid price target lowered to $9 from $18 at Deutsche Bank
09/24/20 Evercore ISI
Rite Aid price target lowered to $4 from $6 at Evercore ISI
RAD Rite Aid
$12.57 /

+ (+0.00%)

RAD Rite Aid
$12.57 /

+ (+0.00%)

RAD Rite Aid
$12.57 /

+ (+0.00%)

RAD Rite Aid
$12.57 /

+ (+0.00%)

Hot Stocks
Palantir falls after Citron announces short position with $20 target » 10:15
11/27/20
11/27
10:15
11/27/20
10:15
PLTR

Palantir

$31.00 /

+1.97 (+6.79%)

Shares of Palantir moved…

Shares of Palantir moved lower after Andrew Left's Citron Research announced a new short position in the name with $20 year-end price target. The stock in morning trading is well off the day's highs but remains up 47c to $29.52. Citron said via Twitter, "What a run the past month for all. But as traders looking for short exposure, $PLTR is no longer a stock but a full casino. Does not take a ball of crystal to know this will fall back to Arda. Shorting with a $20 2020 target."

ShowHide Related Items >><<
PLTR Palantir
$31.00 /

+1.97 (+6.79%)

PLTR Palantir
$31.00 /

+1.97 (+6.79%)

11/13/20
Fly Intel: Top five analyst downgrades
11/13/20 Jefferies
Palantir price target raised to $18 from $13 at Jefferies
11/13/20 RBC Capital
Palantir price target raised to $15 from $11 at RBC Capital
11/13/20 Morgan Stanley
Morgan Stanley downgrades Palantir to Equal Weight after spike in share price
PLTR Palantir
$31.00 /

+1.97 (+6.79%)

PLTR Palantir
$31.00 /

+1.97 (+6.79%)

PLTR Palantir
$31.00 /

+1.97 (+6.79%)

PLTR Palantir
$31.00 /

+1.97 (+6.79%)

Conference/Events
Ambarella participates in a conference call with MKM Partners » 10:14
11/27/20
11/27
10:14
11/27/20
10:14
AMBA

Ambarella

$79.15 /

+3.22 (+4.24%)

Conference call with CFO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMBA Ambarella
$79.15 /

+3.22 (+4.24%)

AMBA Ambarella
$79.15 /

+3.22 (+4.24%)

11/24/20 Needham
Ambarella price target raised to $80 from $63 at Needham
11/24/20 Craig-Hallum
Ambarella price target raised to $90 from $75 at Craig-Hallum
11/24/20 Stifel
Ambarella price target raised to $78 from $66 at Stifel
11/24/20 Morgan Stanley
Ambarella price target raised to $83 from $79 at Morgan Stanley
AMBA Ambarella
$79.15 /

+3.22 (+4.24%)

AMBA Ambarella
$79.15 /

+3.22 (+4.24%)

AMBA Ambarella
$79.15 /

+3.22 (+4.24%)

Periodicals
Citron shorting Palantir, sees $20 stock by end of 2020 » 10:13
11/27/20
11/27
10:13
11/27/20
10:13
PLTR

Palantir

$31.00 /

+1.97 (+6.79%)

Andrew Left Citron…

Andrew Left Citron Research said via Twitter, "What a run the past month for all. But as traders looking for short exposure, $PLTR is no longer a stock but a full casino. Does not take a ball of crystal to know this will fall back to Arda. Shorting with a $20 2020 target."

ShowHide Related Items >><<
PLTR Palantir
$31.00 /

+1.97 (+6.79%)

PLTR Palantir
$31.00 /

+1.97 (+6.79%)

11/13/20
Fly Intel: Top five analyst downgrades
11/13/20 Jefferies
Palantir price target raised to $18 from $13 at Jefferies
11/13/20 RBC Capital
Palantir price target raised to $15 from $11 at RBC Capital
11/13/20 Morgan Stanley
Morgan Stanley downgrades Palantir to Equal Weight after spike in share price
PLTR Palantir
$31.00 /

+1.97 (+6.79%)

PLTR Palantir
$31.00 /

+1.97 (+6.79%)

PLTR Palantir
$31.00 /

+1.97 (+6.79%)

PLTR Palantir
$31.00 /

+1.97 (+6.79%)

Hot Stocks
Indivior falls after Reckitt files GBP 1.07B suit over demerger » 10:12
11/27/20
11/27
10:12
11/27/20
10:12
INVVY

Indivior

$0.00 /

+ (+0.00%)

, RBGLY

Reckitt Benckiser

$0.00 /

+ (+0.00%)

Indivior (INVVY) said it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INVVY Indivior
$0.00 /

+ (+0.00%)

INVVY Indivior
$0.00 /

+ (+0.00%)

07/27/20 Citi
Indivior upgraded to Buy from Neutral at Citi
07/27/20 Jefferies
Indivior upgraded to Buy from Hold at Jefferies
07/27/20 Stifel
Indivior upgraded to Buy from Hold at Stifel
RBGLY Reckitt Benckiser
$0.00 /

+ (+0.00%)

11/19/20 Jefferies
Reckitt Benckiser downgraded to Underperform from Hold at Jefferies
11/11/20 Credit Suisse
Reckitt Benckiser upgraded to Outperform from Neutral at Credit Suisse
11/06/20 RBC Capital
Reckitt Benckiser upgraded to Sector Perform from Underperform at RBC Capital
10/23/20 Berenberg
Reckitt Benckiser price target raised to 9,100 GBp from 9,000 GBp at Berenberg
Conference/Events
Trillium Therapeutics to host conference call » 10:09
11/27/20
11/27
10:09
11/27/20
10:09
TRIL

Trillium Therapeutics

$19.08 /

+1.67 (+9.59%)

Management provides a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRIL Trillium Therapeutics
$19.08 /

+1.67 (+9.59%)

TRIL Trillium Therapeutics
$19.08 /

+1.67 (+9.59%)

11/18/20 Craig-Hallum
Trillium Therapeutics price target raised to $21 from $15 at Craig-Hallum
11/04/20 Cowen
Trillium ASH abstracts provide 'minimal updates', says Cowen
10/12/20 Evercore ISI
Trillium Therapeutics initiated with an Outperform at Evercore ISI
10/05/20 Piper Sandler
Patent fight likely to weigh on ALX Oncology shares NT, says Piper Sandler
TRIL Trillium Therapeutics
$19.08 /

+1.67 (+9.59%)

  • 11
    Sep
  • 23
    Jan
TRIL Trillium Therapeutics
$19.08 /

+1.67 (+9.59%)

TRIL Trillium Therapeutics
$19.08 /

+1.67 (+9.59%)

Options
Plug Power call volume above normal and directionally bullish » 10:05
11/27/20
11/27
10:05
11/27/20
10:05
PLUG

Plug Power

$27.62 /

+1.47 (+5.62%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLUG Plug Power
$27.62 /

+1.47 (+5.62%)

PLUG Plug Power
$27.62 /

+1.47 (+5.62%)

11/12/20 Canaccord
Plug Power price target raised to $25 from $13 at Canaccord
11/10/20 Craig-Hallum
Plug Power price target raised to $26 from $14 at Craig-Hallum
11/10/20 B. Riley Securities
Plug Power price target raised to $24 from $18 at B. Riley Securities
11/10/20 Roth Capital
Plug Power price target raised to $22 from $13 at Roth Capital
PLUG Plug Power
$27.62 /

+1.47 (+5.62%)

  • 17
    Nov
  • 12
    Aug
  • 06
    Dec
PLUG Plug Power
$27.62 /

+1.47 (+5.62%)

PLUG Plug Power
$27.62 /

+1.47 (+5.62%)

PLUG Plug Power
$27.62 /

+1.47 (+5.62%)

General news
Oil Action: WTI crude » 10:00
11/27/20
11/27
10:00
11/27/20
10:00

Oil Action: WTI crude is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Options
Elanco Animal Health put volume heavy and directionally bearish » 09:55
11/27/20
11/27
09:55
11/27/20
09:55
ELAN

Elanco

$32.00 /

+0.23 (+0.72%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ELAN Elanco
$32.00 /

+0.23 (+0.72%)

ELAN Elanco
$32.00 /

+0.23 (+0.72%)

11/23/20 Morgan Stanley
Elanco price target raised to $41 from $31 at Morgan Stanley
11/17/20 Citi
Citi boosts Elanco target to $35, opens 'positive catalyst watch'
11/09/20
Fly Intel: Top five analyst downgrades
11/09/20 Barclays
Barclays double downgrades Elanco to Underweight with $25 target
ELAN Elanco
$32.00 /

+0.23 (+0.72%)

  • 23
    Jan
ELAN Elanco
$32.00 /

+0.23 (+0.72%)

ELAN Elanco
$32.00 /

+0.23 (+0.72%)

ELAN Elanco
$32.00 /

+0.23 (+0.72%)

Options
Early notable gainers among liquid option names on November 27th » 09:55
11/27/20
11/27
09:55
11/27/20
09:55
FSLR

First Solar

$95.19 /

+2.81 (+3.04%)

, CF

CF Industries

$39.15 /

+0.98 (+2.57%)

, AMAT

Applied Materials

$82.94 /

+1.81 (+2.23%)

, LRCX

Lam Research

$457.00 /

+9.86 (+2.21%)

, ECL

Ecolab

$220.71 /

+2.61 (+1.20%)

Notable gainers among…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FSLR First Solar
$95.19 /

+2.81 (+3.04%)

CF CF Industries
$39.15 /

+0.98 (+2.57%)

AMAT Applied Materials
$82.94 /

+1.81 (+2.23%)

LRCX Lam Research
$457.00 /

+9.86 (+2.21%)

ECL Ecolab
$220.71 /

+2.61 (+1.20%)

FSLR First Solar
$95.19 /

+2.81 (+3.04%)

11/10/20
Fly Intel: Top five analyst downgrades
11/10/20 Raymond James
Raymond James double downgrades First Solar to Underperform on Biden election
11/10/20 Raymond James
First Solar downgraded to Underperform from Outperform at Raymond James
11/09/20 Goldman Sachs
First Solar downgraded to Buy from Conviction Buy at Goldman Sachs
CF CF Industries
$39.15 /

+0.98 (+2.57%)

11/23/20
Fly Intel: Top five analyst upgrades
11/23/20 Stephens
CF Industries upgraded to Overweight on recovery expectations at Stephens
11/23/20 Stephens
CF Industries upgraded to Overweight from Equal Weight at Stephens
11/11/20 JPMorgan
CF Industries price target lowered to $38 from $45 at JPMorgan
AMAT Applied Materials
$82.94 /

+1.81 (+2.23%)

11/16/20 Argus
Applied Materials price target raised to $90 from $80 at Argus
11/13/20 DA Davidson
Applied Materials price target raised to $78 from $70 at DA Davidson
11/13/20 JPMorgan
Applied Materials price target raised to $88 from $84 at JPMorgan
11/13/20 Needham
Applied Materials price target raised to $82 from $76 at Needham
LRCX Lam Research
$457.00 /

+9.86 (+2.21%)

11/23/20 KeyBanc
Lam Research price target raised to $472 from $424 at KeyBanc
11/19/20 Citi
Citi moves Lam Research, Marvell to top picks in Semi Equipment
11/06/20 Susquehanna
Lam Research price target raised to $500 from $425 at Susquehanna
10/22/20 B. Riley Securities
Lam Research price target raised to $465 from $450 at B. Riley Securities
ECL Ecolab
$220.71 /

+2.61 (+1.20%)

11/23/20 Morgan Stanley
Ecolab price target raised to $210 from $170 at Morgan Stanley
10/28/20 Credit Suisse
Ecolab price target raised to $180 from $172 at Credit Suisse
10/28/20 BMO Capital
Ecolab price target raised to $195 from $187 at BMO Capital
10/28/20 Deutsche Bank
Ecolab price target lowered to $200 from $210 at Deutsche Bank
FSLR First Solar
$95.19 /

+2.81 (+3.04%)

CF CF Industries
$39.15 /

+0.98 (+2.57%)

AMAT Applied Materials
$82.94 /

+1.81 (+2.23%)

LRCX Lam Research
$457.00 /

+9.86 (+2.21%)

ECL Ecolab
$220.71 /

+2.61 (+1.20%)

  • 17
    Sep
FSLR First Solar
$95.19 /

+2.81 (+3.04%)

CF CF Industries
$39.15 /

+0.98 (+2.57%)

AMAT Applied Materials
$82.94 /

+1.81 (+2.23%)

LRCX Lam Research
$457.00 /

+9.86 (+2.21%)

FSLR First Solar
$95.19 /

+2.81 (+3.04%)

AMAT Applied Materials
$82.94 /

+1.81 (+2.23%)

LRCX Lam Research
$457.00 /

+9.86 (+2.21%)

ECL Ecolab
$220.71 /

+2.61 (+1.20%)

FSLR First Solar
$95.19 /

+2.81 (+3.04%)

CF CF Industries
$39.15 /

+0.98 (+2.57%)

AMAT Applied Materials
$82.94 /

+1.81 (+2.23%)

LRCX Lam Research
$457.00 /

+9.86 (+2.21%)

ECL Ecolab
$220.71 /

+2.61 (+1.20%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.